These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 33093563)
1. Transport of ultrasmall gold nanoparticles (2 nm) across the blood-brain barrier in a six-cell brain spheroid model. Sokolova V; Mekky G; van der Meer SB; Seeds MC; Atala AJ; Epple M Sci Rep; 2020 Oct; 10(1):18033. PubMed ID: 33093563 [TBL] [Abstract][Full Text] [Related]
2. Ultrasmall gold nanoparticles (2 nm) can penetrate and enter cell nuclei in an in vitro 3D brain spheroid model. Sokolova V; Nzou G; van der Meer SB; Ruks T; Heggen M; Loza K; Hagemann N; Murke F; Giebel B; Hermann DM; Atala AJ; Epple M Acta Biomater; 2020 Jul; 111():349-362. PubMed ID: 32413579 [TBL] [Abstract][Full Text] [Related]
3. Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents. Cho CF; Wolfe JM; Fadzen CM; Calligaris D; Hornburg K; Chiocca EA; Agar NYR; Pentelute BL; Lawler SE Nat Commun; 2017 Jun; 8():15623. PubMed ID: 28585535 [TBL] [Abstract][Full Text] [Related]
4. The Application of Ultrasmall Gold Nanoparticles (2 nm) Functionalized with Doxorubicin in Three-Dimensional Normal and Glioblastoma Organoid Models of the Blood-Brain Barrier. Kostka K; Sokolova V; El-Taibany A; Kruse B; Porada D; Wolff N; Prymak O; Seeds MC; Epple M; Atala AJ Molecules; 2024 May; 29(11):. PubMed ID: 38893345 [TBL] [Abstract][Full Text] [Related]
5. Development, Characterization and Potential Applications of a Multicellular Spheroidal Human Blood-Brain Barrier Model Integrating Three Conditionally Immortalized Cell Lines. Kitamura K; Umehara K; Ito R; Yamaura Y; Komori T; Morio H; Akita H; Furihata T Biol Pharm Bull; 2021 Jul; 44(7):984-991. PubMed ID: 33896887 [TBL] [Abstract][Full Text] [Related]
6. Uptake of Functional Ultrasmall Gold Nanoparticles in 3D Gut Cell Models. Sokolova V; Ebel JF; Kollenda S; Klein K; Kruse B; Veltkamp C; Lange CM; Westendorf AM; Epple M Small; 2022 Aug; 18(31):e2201167. PubMed ID: 35712760 [TBL] [Abstract][Full Text] [Related]
7. Multicellular self-assembled spheroidal model of the blood brain barrier. Urich E; Patsch C; Aigner S; Graf M; Iacone R; Freskgård PO Sci Rep; 2013; 3():1500. PubMed ID: 23511305 [TBL] [Abstract][Full Text] [Related]
8. Pericyte-Specific Secretome Profiling in Hypoxia Using TurboID in a Multicellular in Vitro Spheroid Model. Enström A; Carlsson R; Buizza C; Lewi M; Paul G Mol Cell Proteomics; 2024 Jun; 23(6):100782. PubMed ID: 38705386 [TBL] [Abstract][Full Text] [Related]
9. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869 [TBL] [Abstract][Full Text] [Related]
10. Spontaneous penetration of gold nanoparticles through the blood brain barrier (BBB). Sela H; Cohen H; Elia P; Zach R; Karpas Z; Zeiri Y J Nanobiotechnology; 2015 Oct; 13():71. PubMed ID: 26489846 [TBL] [Abstract][Full Text] [Related]
11. A Microfluidic Multisize Spheroid Array for Multiparametric Screening of Anticancer Drugs and Blood-Brain Barrier Transport Properties. Eilenberger C; Rothbauer M; Selinger F; Gerhartl A; Jordan C; Harasek M; Schädl B; Grillari J; Weghuber J; Neuhaus W; Küpcü S; Ertl P Adv Sci (Weinh); 2021 Jun; 8(11):e2004856. PubMed ID: 34105271 [TBL] [Abstract][Full Text] [Related]
12. Suitability of 3D human brain spheroid models to distinguish toxic effects of gold and poly-lactic acid nanoparticles to assess biocompatibility for brain drug delivery. Leite PEC; Pereira MR; Harris G; Pamies D; Dos Santos LMG; Granjeiro JM; Hogberg HT; Hartung T; Smirnova L Part Fibre Toxicol; 2019 Jun; 16(1):22. PubMed ID: 31159811 [TBL] [Abstract][Full Text] [Related]
13. Nanoparticle accumulation and transcytosis in brain endothelial cell layers. Ye D; Raghnaill MN; Bramini M; Mahon E; Åberg C; Salvati A; Dawson KA Nanoscale; 2013 Nov; 5(22):11153-65. PubMed ID: 24077327 [TBL] [Abstract][Full Text] [Related]
14. Blood-brain-barrier organoids for investigating the permeability of CNS therapeutics. Bergmann S; Lawler SE; Qu Y; Fadzen CM; Wolfe JM; Regan MS; Pentelute BL; Agar NYR; Cho CF Nat Protoc; 2018 Dec; 13(12):2827-2843. PubMed ID: 30382243 [TBL] [Abstract][Full Text] [Related]
15. A Human Immortalized Cell-Based Blood-Brain Barrier Triculture Model: Development and Characterization as a Promising Tool for Drug-Brain Permeability Studies. Ito R; Umehara K; Suzuki S; Kitamura K; Nunoya KI; Yamaura Y; Imawaka H; Izumi S; Wakayama N; Komori T; Anzai N; Akita H; Furihata T Mol Pharm; 2019 Nov; 16(11):4461-4471. PubMed ID: 31573814 [TBL] [Abstract][Full Text] [Related]
17. A filter-free blood-brain barrier model to quantitatively study transendothelial delivery of nanoparticles by fluorescence spectroscopy. De Jong E; Williams DS; Abdelmohsen LKEA; Van Hest JCM; Zuhorn IS J Control Release; 2018 Nov; 289():14-22. PubMed ID: 30243824 [TBL] [Abstract][Full Text] [Related]
18. Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood-brain barrier penetration models. Hellinger E; Veszelka S; Tóth AE; Walter F; Kittel A; Bakk ML; Tihanyi K; Háda V; Nakagawa S; Duy TD; Niwa M; Deli MA; Vastag M Eur J Pharm Biopharm; 2012 Oct; 82(2):340-51. PubMed ID: 22906709 [TBL] [Abstract][Full Text] [Related]
19. Human Cortex Spheroid with a Functional Blood Brain Barrier for High-Throughput Neurotoxicity Screening and Disease Modeling. Nzou G; Wicks RT; Wicks EE; Seale SA; Sane CH; Chen A; Murphy SV; Jackson JD; Atala AJ Sci Rep; 2018 May; 8(1):7413. PubMed ID: 29743549 [TBL] [Abstract][Full Text] [Related]